These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10347201)

  • 1. Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells.
    Martin JL; Baxter RC
    J Biol Chem; 1999 Jun; 274(23):16407-11. PubMed ID: 10347201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases.
    Martin JL; Weenink SM; Baxter RC
    J Biol Chem; 2003 Jan; 278(5):2969-76. PubMed ID: 12433918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells.
    Kim HS; Ingermann AR; Tsubaki J; Twigg SM; Walker GE; Oh Y
    Cancer Res; 2004 Mar; 64(6):2229-37. PubMed ID: 15026367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways.
    Kuemmerle JF; Zhou H
    J Biol Chem; 2002 Jun; 277(23):20563-71. PubMed ID: 11923300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium butyrate on expression of members of the IGF-binding protein superfamily in human mammary epithelial cells.
    Tsubaki J; Choi WK; Ingermann AR; Twigg SM; Kim HS; Rosenfeld RG; Oh Y
    J Endocrinol; 2001 Apr; 169(1):97-110. PubMed ID: 11250651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
    Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
    Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
    Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
    J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.
    McCaig C; Fowler CA; Laurence NJ; Lai T; Savage PB; Holly JM; Perks CM
    Br J Cancer; 2002 Jun; 86(12):1963-9. PubMed ID: 12085194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo.
    Butt AJ; Dickson KA; McDougall F; Baxter RC
    J Biol Chem; 2003 Aug; 278(32):29676-85. PubMed ID: 12777377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
    Fanayan S; Firth SM; Butt AJ; Baxter RC
    J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction.
    Salahifar H; Baxter RC; Martin JL
    Endocrinology; 1997 Apr; 138(4):1683-90. PubMed ID: 9075731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells.
    Perks CM; McCaig C; Clarke JB; Clemmons DR; Holly JM
    Biochem Biophys Res Commun; 2002 Jun; 294(5):988-94. PubMed ID: 12074574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway.
    Ricort JM; Binoux M
    J Biol Chem; 2002 May; 277(22):19448-54. PubMed ID: 11940579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes.
    Burrows C; Holly JM; Laurence NJ; Vernon EG; Carter JV; Clark MA; McIntosh J; McCaig C; Winters ZE; Perks CM
    Endocrinology; 2006 Jul; 147(7):3484-500. PubMed ID: 16614079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria.
    Perks CM; McCaig C; Holly JM
    J Cell Biochem; 2000 Oct; 80(2):248-58. PubMed ID: 11074596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-3 mediates IGF-I action in a bovine mammary epithelial cell line independent of an IGF interaction.
    Grill CJ; Cohick WS
    J Cell Physiol; 2000 May; 183(2):273-83. PubMed ID: 10737903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1beta: requirement of the mitogen-activated protein kinase pathway.
    Frost RA; Nystrom GJ; Lang CH
    Endocrinology; 2000 Sep; 141(9):3156-64. PubMed ID: 10965886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells.
    Schedlich LJ; O'Han MK; Leong GM; Baxter RC
    Biochem Biophys Res Commun; 2004 Jan; 314(1):83-8. PubMed ID: 14715249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.